Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Provided By GlobeNewswire
Last update: Dec 9, 2025
JUPITER, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) will host its Investor Day in New York City today. The event will include presentations from the Ligand senior management team highlighting the company’s strategy, investment activity, royalty portfolio, and long-term financial outlook. Scott Plesha, CEO of Pelthos Therapeutics, a Ligand partner, will also discuss the recent launch of Zelsuvmi.
Read more at globenewswire.com
